| Literature DB >> 33964817 |
Ines Martin1, Fred Braem2, Lia Baudet2, William Poncin1, Stéphane Fizaine2, Frank Aboubakar3, Antoine Froidure3, Charles Pilette3, Giuseppe Liistro3, Julien De Greef4, Halil Yildiz4, Lucie Pothen4, Jean-Cyr Yombi5, Leïla Belkhir5, Gregory Reychler6.
Abstract
BACKGROUND: The impact of the COVID-19 pandemic on functional exercise capacity seemed quickly clinically evident. The objective of this study was to assess the functional exercise capacity of patients with severe COVID-19 and to evaluate the effect of a telerehabilitation program in the specific context of the COVID-19 pandemic.Entities:
Keywords: COVID; Functional exercise capacity; Telerehabilitation
Year: 2021 PMID: 33964817 PMCID: PMC8084600 DOI: 10.1016/j.rmed.2021.106438
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415
Demographic characteristics of the patients in the different groups.
| Total n = 48 (baseline) | Telerehabilitation n = 14 | Control n = 13 | p value (tele vs control) | |
|---|---|---|---|---|
| Age (years) | 61.5 ± 10.5 [58.5; 64.6] | 60.8 ± 10.4 [55.6; 65.9] | 61.9 ± 10.7 [57.9; 66.0] | 0.990 |
| Gender (M/F) | 28/20 | 11/3 | 6/7 | 0.082 |
| Weight (kg) | 88.6 ± 21.7 [81.1; 96.0] | 95.3 ± 27.6 [80.0; 110.5] | 83.6 ± 14.8 [76.6; 90.5] | 0.191 |
| Height (cm) | 167.6 ± 18.8 [161.8; 173.4] | 168.6 ± 29.6 [152.8; 184.3] | 167.0 ± 8.1 [163.8; 170.2] | 0.786 |
| BMI (kg/cm2) | 29.0 ± 4.7 [27.4; 30.6] | 29.7 ± 5.2 [27.3; 32.2] | 28.1 ± 3.9 [26.0; 30.3] | 0.324 |
| ICU (y/n) | 13/35 | 4/10 | 2/11 | 0.410 |
| Length of stay (d) | 16.1 ± 9.1 [5.0; 16.5] | 16.3 ± 9.6 [11.6; 21.1] | 16.1 ± 9.1 [12.7; 19.5] | 0.317 |
| Oxygen (y/n) | 44/4 | 12/2 | 12/1 | 0.586 |
Data are presented as mean ± standard deviation [CI95%] or proportions.
*: significant difference between groups.
M: male; F: female; ICU: intensive care unit; y/n: yes/no; d: day.
Lung function parameters of the patients at 3 months of follow up.
| Total n = 27 | |
|---|---|
| DLCO (% pred) | 79.2 ± 18.2 |
| FEV1/FVC (% pred) | 102.5 ± 12.6 |
| FEV1 (% pred) | 90.6 ± 25.2 |
| FVC (% pred) | 90.0 ± 19.8 |
| IC (% pred) | 99.2 ± 23.0 |
Data are presented as mean ± standard deviation.
DLCO: lung diffusing capacity for carbon monoxide; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; IC: inspiratory capacity.
Comparison of the results from the telerehabilitation and control groups.
| Telerehabilitation (n = 14) | Control (n = 13) | p value | |
|---|---|---|---|
| At discharge | |||
| SpO2i (%) | 95.1 ± 1.9 [94.2; 96.1] | 94.8 ± 1.9 [93.8; 95.8] | 0.655 |
| HRi (bpm) | 90.5 ± 17.3 [81.5; 99.6] | 86.2 ± 15.3 [77.9; 94.5] | 0.547 |
| Dyspneai | 0 (0–3) | 2 (0–5) | 0.836 |
| STST (n) | 17.6 ± 4.7 [15.1; 20.0] | 13.6 ± 7.6 [9.5; 17.8] | 0.123 |
| SpO2f (%) | 91.8 ± 3.3 [90.0; 93.5] | 92.5 ± 1.7 [91.6; 93.4] | 0.568 |
| HRf (bpm) | 110.5 ± 18.5 [100.8; 120.2] | 102.0 ± 15.4 [93.6; 110.4] | 0.260 |
| Dyspneaf | 5 (3–8) | 5 (1–10) | 0.966 |
| Change between discharge and 3-month follow-up | |||
| Delta HR (bpm) | 42.6 ± 25.2 [29.4; 55.8] | 23.1 ± 12.1 [16.5; 29.7] | 0.036 |
| STST change (n) | 10 (5–19) | 5 (-4–11) | 0.004 |
| Dyspnea change | 2.5 (-2–7) | 2 (0–6) | 0.560 |
Data are presented as mean ± standard deviation or median (range).
SpO2: pulsed oxygen saturation, HR: heart rate; i: initial; f: final; STST: sit-to-stand test; bpm: beat by minute.